Implication of immunokine profiling for cancer staging

Kawngwoo Park, Madhusmita Dhupal, Cheol Su Kim, Yoon Sun Park, Soo-Ki Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Tumor may arise from the dysregulation of immune system, which plays pivotal roles in counteracting tumor colonization, late-stage tumors, and metastases. In the midst of the establishment of cancer in vivo, immune cells are activated to release a multitude of immunokines, such as cytokines, and chemokines. Thus, since cytokine levels in tumor bearing host would be differential among local (intratumoral lesion, peritumoral normal tissue), and systemic sample site (serum), these differences might be significantly correlated to prognosis and treatment outcome for cancer patients. Previously, despite small number of patients, we demonstrated the feasibility of this proposition via only cytokine profiling. Based on this, herein we propose that immunokine profiling would be used as a surrogate, predictive tool for cancer staging, and progression.

Original languageEnglish
Pages (from-to)46-48
Number of pages3
JournalMedical Hypotheses
Volume88
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Neoplasm Staging
Neoplasms
Cytokines
Chemokines
Immune System
Neoplasm Metastasis
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Park, Kawngwoo ; Dhupal, Madhusmita ; Kim, Cheol Su ; Park, Yoon Sun ; Kim, Soo-Ki. / Implication of immunokine profiling for cancer staging. In: Medical Hypotheses. 2016 ; Vol. 88. pp. 46-48.
@article{d56d2a8bf7a44c5ba3dcf88ec7cc9e45,
title = "Implication of immunokine profiling for cancer staging",
abstract = "Tumor may arise from the dysregulation of immune system, which plays pivotal roles in counteracting tumor colonization, late-stage tumors, and metastases. In the midst of the establishment of cancer in vivo, immune cells are activated to release a multitude of immunokines, such as cytokines, and chemokines. Thus, since cytokine levels in tumor bearing host would be differential among local (intratumoral lesion, peritumoral normal tissue), and systemic sample site (serum), these differences might be significantly correlated to prognosis and treatment outcome for cancer patients. Previously, despite small number of patients, we demonstrated the feasibility of this proposition via only cytokine profiling. Based on this, herein we propose that immunokine profiling would be used as a surrogate, predictive tool for cancer staging, and progression.",
author = "Kawngwoo Park and Madhusmita Dhupal and Kim, {Cheol Su} and Park, {Yoon Sun} and Soo-Ki Kim",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.mehy.2016.01.005",
language = "English",
volume = "88",
pages = "46--48",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",

}

Implication of immunokine profiling for cancer staging. / Park, Kawngwoo; Dhupal, Madhusmita; Kim, Cheol Su; Park, Yoon Sun; Kim, Soo-Ki.

In: Medical Hypotheses, Vol. 88, 01.03.2016, p. 46-48.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Implication of immunokine profiling for cancer staging

AU - Park, Kawngwoo

AU - Dhupal, Madhusmita

AU - Kim, Cheol Su

AU - Park, Yoon Sun

AU - Kim, Soo-Ki

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Tumor may arise from the dysregulation of immune system, which plays pivotal roles in counteracting tumor colonization, late-stage tumors, and metastases. In the midst of the establishment of cancer in vivo, immune cells are activated to release a multitude of immunokines, such as cytokines, and chemokines. Thus, since cytokine levels in tumor bearing host would be differential among local (intratumoral lesion, peritumoral normal tissue), and systemic sample site (serum), these differences might be significantly correlated to prognosis and treatment outcome for cancer patients. Previously, despite small number of patients, we demonstrated the feasibility of this proposition via only cytokine profiling. Based on this, herein we propose that immunokine profiling would be used as a surrogate, predictive tool for cancer staging, and progression.

AB - Tumor may arise from the dysregulation of immune system, which plays pivotal roles in counteracting tumor colonization, late-stage tumors, and metastases. In the midst of the establishment of cancer in vivo, immune cells are activated to release a multitude of immunokines, such as cytokines, and chemokines. Thus, since cytokine levels in tumor bearing host would be differential among local (intratumoral lesion, peritumoral normal tissue), and systemic sample site (serum), these differences might be significantly correlated to prognosis and treatment outcome for cancer patients. Previously, despite small number of patients, we demonstrated the feasibility of this proposition via only cytokine profiling. Based on this, herein we propose that immunokine profiling would be used as a surrogate, predictive tool for cancer staging, and progression.

UR - http://www.scopus.com/inward/record.url?scp=84958206136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958206136&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2016.01.005

DO - 10.1016/j.mehy.2016.01.005

M3 - Article

C2 - 26880636

AN - SCOPUS:84958206136

VL - 88

SP - 46

EP - 48

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

ER -